Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tear film lipid layer component (or more precisely, major meibomian lipids of tear film lipid layer)
- Molecular classification
- Other (mixture of lipids), wax esters, cholesterol esters, (O-acyl)-omega-hydroxy fatty acids, triglycerides, free fatty acids, small amounts of polar lipids
01
Overview
The tear film lipid layer is the thin, outermost component of the tear film that covers the ocular surface. It is primarily composed of lipids secreted by the meibomian glands, including wax esters, cholesterol esters, (O-acyl)-omega-hydroxy fatty acids, and minor species of polar lipids. This layer is essential for maintaining tear film stability by reducing evaporation, providing a smooth optical surface, and protecting against microbial invasion. The structural and compositional properties of the lipid layer ensure tear film integrity between blinks, but dysfunction or deficiency of its components—due to internal or environmental factors—can lead to dry eye syndrome and related disorders. It does not represent a single molecular target, but rather a complex mixture of molecules performing vital physical and biological functions.
- Other names
- Tear film lipidsTFLL componentsmeibomian gland secretion (meibum)tear film lipid layeroily layer of tear film
02
Biological functions
Reduces evaporation of tearsStabilizes the tear film at the air/liquid interfaceProvides a smooth optical surface for the corneaFirst defense barrier to bacteria (via detergent effects)Contributes to tear film viscosity and surface tension
03
Disease associations
Dry eye syndrome (deficiency or disruption of components is a major cause of dry eye, particularly due to meibomian gland dysfunction)Surface instability and chronic ocular discomfort
04
Safety considerations
Therapeutic supplementation (topical lipid supplements) may cause blurred vision or irritation if formulation is suboptimalRisk of contamination or destabilization of tear film by foreign lipids (e.g., skin lipids, makeup)
Beyond the preview
Go deeper on Tear film lipid layer component (or more precisely, major meibomian lipids of tear film lipid layer).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tear film lipid layer component (or more precisely, major meibomian lipids of tear film lipid layer).